Primary mucinous epithelial ovarian carcinoma in a patient with ankylosing spondylitis treated with infiiximab: Case report Infliksimab ile tedavi edilen ankilozan spondilitli bir hastada primer müsinöz epitelyal over karsinomu
Turkiye Klinikleri Journal of Medical Sciences, vol.33, no.1, pp.238-240, 2013 (SCI-Expanded)
- Publication Type: Article / Article
- Volume: 33 Issue: 1
- Publication Date: 2013
- Doi Number: 10.5336/medsci.2011-23682
- Journal Name: Turkiye Klinikleri Journal of Medical Sciences
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.238-240
- Keywords: Ankylosing, Infliximab, Ovarian neoplasms, Spondylitis, Tumor necrosis factor alpha (36-68)
- Akdeniz University Affiliated: Yes
Abstract
Ankylosing spondylitis (AS), the prototype of spondyloarthritis is a chronic inflammatory rheumatic disease with a prevalence of 0.5-1.9% among all types of spondyloarthritis. Inhibition of the proinflammatory cytokine tumour necrosis factor (TNF)-α has demonstrated efficacy in patients with active AS. However, de novo malignancies have been reported in some patients undergoing this therapy representing a major concern. Here, we reported a case with AS who was diagnosed with carcinoma of ovary after receiving therapy with infliximab. Copyright © 2013 by Türkiye Klinikleri.